Dermot Kelleher
Director/Miembro de la Junta en Cellix Ltd. .
Cargos activos de Dermot Kelleher
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Cellix Ltd.
 Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Director/Miembro de la Junta | - | - |
| The Institute of Molecular Medicine | Director/Miembro de la Junta | 24/09/2009 | - |
| University of British Columbia | Corporate Officer/Principal | - | - |
Historial de carrera de Dermot Kelleher
Antiguos cargos conocidos de Dermot Kelleher.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Director/Miembro de la Junta | 01/05/2008 | 25/07/2019 |
| Independent Dir/Board Member | 01/05/2008 | 25/07/2019 | |
| Lee Kong Chian School of Medicine | Corporate Officer/Principal | 01/01/2012 | 01/01/2014 |
| Trinity College Dublin | Corporate Officer/Principal | 01/01/2004 | 01/01/2012 |
| Federation of European Academies of Medicine | Presidente | - | - |
| Imperial College London | Corporate Officer/Principal | - | - |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Fundador | 01/01/2004 | - |
Estadísticas
Internacional
| Irlanda | 5 |
| Reino Unido | 2 |
| Canadá | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| Empresas privadas | 4 |
|---|---|
Cellix Ltd.
Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
| The Institute of Molecular Medicine | |
| Federation of European Academies of Medicine |
- Bolsa de valores
- Insiders
- Dermot Kelleher
- Experiencia
